Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Hecht Peter M Create: Alert

All | News | Filings
Date FiledTypeDescription
05/23/2023 SC 13D/A Hecht Peter M has filed a Schedule 13D for Cyclerion Therapeutics, Inc.
05/22/2023 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 225,000 shares @ $8.68, valued at $2M
Granted 351,037 convertible preferred @ $0
05/12/2023 SC 13D/A Hecht Peter M has filed a Schedule 13D for Cyclerion Therapeutics, Inc.
04/03/2023 SC 13D/A Hecht Peter M has filed a Schedule 13D for Cyclerion Therapeutics, Inc.
11/21/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/24/2022 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 52,950 options to buy @ $1.78, valued at $94.3k
Granted 430,000 options to buy @ $1.21, valued at $520.3k
06/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/14/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
05/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2020 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 153,846 options to buy @ $2.65, valued at $407.7k
11/26/2019 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $2.01, valued at $150.8k
09/20/2019 4/A Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 221,736 shares @ $0
Granted 53,083 options to buy @ $0
Granted 36,088 options to buy @ $16.21, valued at $585k
Granted 43,679 options to buy @ $14.4, valued at $629k
Granted 37,972 options to buy @ $15.54, valued at $590.1k
Granted 223,893 options to buy @ $11.28, valued at $2.5M
Granted 344,777 options to buy @ $0
Granted 380,330 options to buy @ $16.02, valued at $6.1M
Granted 857,830 options to buy @ $0
07/12/2019 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Exercised 2,000 options to buy @ $6.04, valued at $12.1k
04/03/2019 4 Hecht Peter M (CEO) has filed a Form 4 on Cyclerion Therapeutics, Inc.
Txns: Granted 223,192 shares @ $0
Granted 485 shares @ $0
Granted 2,000 options to buy @ $0
Granted 12,499 options to buy @ $0
Granted 53,090 options to buy @ $0
Granted 36,089 options to buy @ $0
Granted 43,680 options to buy @ $0
Granted 37,973 options to buy @ $0
Granted 56,500 options to buy @ $0
Granted 223,919 options to buy @ $0
Granted 344,829 options to buy @ $0
04/03/2019 3 Hecht Peter M (CEO) has filed a Form 3 on Cyclerion Therapeutics, Inc.
04/03/2019 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Disposed/sold 20,000 options to buy @ $0
Disposed/sold 44,020 options to buy @ $0
Disposed/sold 7,533 options to buy @ $0
Disposed/sold 7,645 options to buy @ $0
Disposed/sold 6,771 options to buy @ $0
Disposed/sold 166,875 options to buy @ $0
Disposed/sold 332,500 options to buy @ $0
Disposed/sold 398,750 options to buy @ $0
Disposed/sold 937,500 options to buy @ $0
03/06/2019 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Gifted 2,500,000 shares @ $0
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2019 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 30,000 shares @ $12.66, valued at $379.8k
Sold 30,000 shares @ $12.7, valued at $381k
Sold 29,551 shares @ $12.23, valued at $361.4k
Exercised 30,000 options to buy @ $4.89, valued at $146.7k
Exercised 30,000 options to buy @ $4.89, valued at $146.7k
Exercised 29,551 options to buy @ $4.89, valued at $144.5k
Exercised 20,449 options to buy @ $4.89, valued at $100k
01/03/2019 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Disposed of 4,696,917 shares @ $0
Acquired 4,696,917 shares @ $0
Disposed of 110,000 options to buy @ $4.89, valued at $537.9k
Acquired 110,000 options to buy @ $4.89, valued at $537.9k
Disposed of 40,000 options to buy @ $5.48, valued at $219.2k
Acquired 40,000 options to buy @ $5.48, valued at $219.2k
02/22/2018 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 580,000 options to buy @ $14.55, valued at $8.4M
12/08/2017 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 56,000 shares @ $15.24, valued at $853.4k
Sold 57,405 shares @ $15, valued at $861.1k
Exercised 26,595 options to buy @ $3.76, valued at $100k
Exercised 56,000 options to buy @ $3.76, valued at $210.6k
Exercised 57,405 options to buy @ $3.76, valued at $215.8k
03/01/2017 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 760,000 options to buy @ $16.77, valued at $12.7M
01/13/2017 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Sold 32,993 shares @ $15.84, valued at $522.6k
Sold 32,994 shares @ $15.5, valued at $511.4k
Exercised 32,993 options to buy @ $2.94, valued at $97k
Exercised 32,994 options to buy @ $2.94, valued at $97k
03/11/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/29/2013 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Acquired 615 shares @ $0
11/06/2012 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Bought 50,000 shares @ $11.65, valued at $582.5k
08/17/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
04/09/2012 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Exercised 50,000 options to buy @ $0.41, valued at $20.5k
Exercised 100,000 options to buy @ $0.41, valued at $41k
05/31/2011 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Gifted 860 shares @ $0
02/03/2011 4 Hecht Peter M (CEO) has filed a Form 4 on IRONWOOD PHARMACEUTICALS INC
Txns: Granted 175,000 options to buy @ $11.11, valued at $1.9M
12/28/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy